Cardioprotection of Interleukin-2 Is Mediated via κ-Opioid Receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 2, 2004, Pages 560-567

  Cao, Chun Mei ^a   Xia, Qiang ^b   Tu, Jie ^b   Chen, Mai ^a   Wu, Song ^a   Wong, Tak Ming ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 5 HYDROXYDECANOIC ACID; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; CHELERYTHRINE; GLIBENCLAMIDE; INTERLEUKIN 2; KAPPA OPIATE RECEPTOR; LACTATE DEHYDROGENASE; NALTRINDOLE; NORBINALTORPHIMINE; POTASSIUM CHANNEL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; TIOPRONIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; HEART INFARCTION SIZE; HEART INJURY; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOTONIC AGENTS; INTERLEUKIN-2; L-LACTATE DEHYDROGENASE; MALE; MEMBRANE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNELS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, OPIOID, KAPPA; SIGNAL TRANSDUCTION; TIME FACTORS; VENTRICULAR FUNCTION;

EID: 2142698605     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.061135     Document Type: Article

References (44)

1. Ahmet I, Sawa Y, Nishimura M, Ichikawa H, and Matsuda H (2000) Diadenosine tetraphosphate (AP4A) mimics cardioprotective effect of ischemic preconditioning in the rat heart: contribution of KATP channel and PKC. Basic Res Cardiol 95:235-242.
2. Auchampach JA, Grover GJ, and Gross GJ (1992) Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 26:1054-1062.
3. Baines CP, Goto M, and Downey JM (1997) Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 29:207-216.
4. Benamar K, Geller EB, and Adler MW (2002) Effect of a mu-opioid receptor-selective antagonist on interleukin-6 fever. Life Sci 70:2139-2145.
5. Bolli R (2000) The late phase of preconditioning. Circ Res 87:972-983.
6. 2+]i transient and contraction in isolated ventricular myocytes of the rat. Pfluegers Arch 443:635-642.
7. Cao CM, Ye S, Yu H, Xu QS, Ye ZG, Shen YL, Lu Y, and Xia Q (2003) Interleukin-2 induced endothelium-dependent relaxation of rat thoracic aorta. Sheng Li Xue Bao 55:19-23.
8. 2+ in the rat heart as revealed by kappa-opioid receptor stimulation with U50488H. Br J Pharmacol 140:750-758.
9. Cohen MV, Yang XM, Liu GS, Heusch G, and Downey JM (2001) Acetylcholine, bradykinin, opioids and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res 89:273-278.
10. De Sarro GB, Masuda Y, Ascioti C, Audino MG, and Nistico G (1990) Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology 29:167-179.
11. Gross GJ and Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223-233.
12. Han J, Kim E, Ho WK, and Earm YE (1996) Sulfhydryl redox modulates ATP-sensitive K+ channels in rabbit ventricular myocytes. Biochem Biophys Res Commun 219:900-903.
13. Hanley PJ, Gopalan KV, Lareau RA, Srivastava DK, von Meltzer M, and Daut J (2003) Beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels. J Physiol (Lond) 547:387-393.
14. Herskowitz A, Choi S, Ansari AA, and Wesselingh S (1995) Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 146:419-428.
15. Jiang CL, Son LX, Lu CL, You ZD, Wang YX, Sun LY, Cui RY, and Liu XY (2000a) Analgesic effect of interferon-alpha via mu opioid receptor in the rat. Neurochem Int 36:193-196.
16. Jiang CL, Xu D, Lu CL, Wang YX, You ZD, and Liu XY (2000b) Interleukin-2: structural and biological relatedness to opioid peptides. Neuroimmunomodulation 8:20-24.
17. Kay NE, Morley JE, and Allen JI (1990) Interaction between endogenous opioids and IL-2 on PHA-stimulated human lymphocytes. Immunology 70:485-491.
18. Klawitter PF, Murray HN, Clanton TL, and Angelos MG (2002) Reactive oxygen species generated during myocardial ischemia enable energetic recovery during reperfusion. Am J Physiol 283:H1656-H1661.
19. Krenz M, Oldenburg O, Wimpee H, Cohen MV, Garlid KD, Critz SD, Downey JM, and Benoit JN (2002) Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol 97:365-373.
20. Li DY, Zhang YC, Philips MI, Sawamura T, and Mehta JL (1999) Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res 84:1043-1049.
21. Liang BT (1997) Protein kinase C-mediated preconditioning of cardiac myocytes: role of adenosine receptor and KATP channel. Am J Physiol 273:H847-H853.
22. Makino M, Kitano Y, Komiyama C, Hirohashi M, and Takasuna K (2000) Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test. Br J Pharmacol 130:1269-1274.
23. Maulik N, Engelman RM, Wei Z, Lu D, Rousou JA, and Das DK (1993) Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. Circulation 88:II387-II394.
24. McPherson BC and Yao Z (2001a) Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes. Circulation 103:290-295.
25. McPherson BC and Yao Z (2001b) Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. Anesthesiology 94:1082-1088.
26. Murry CE, Jennings RB, and Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136.
27. Nakano A, Cohen MV, and Downey JM (2000) Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther 86:263-275.
28. Portoghese PS, Lin CE, Farouz-Grant F, and Takemori AE (1994) Structure-activity relationship of N17′-substituted norbinaltorphimine congeners. Role of the N17′ basic group in the interaction with a putative address subsite on the kappa opioid receptor. J Med Chem 37:1495-1500.
29. Portoghese PS, Sultana M, and Takemori AE (1988) Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol 146:185-186.
30. Schoffelmeer AN, Hogenboom F, and Mulder AH (1997) κ1- And κ2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br J Pharmacol 122:520-524.
31. Simkhovich BZ, Przyklenk K, and Kloner RA (1998) Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res 40:9-22.
32. Song P and Zhao Z (2000) Interleukin 2-induced antinociception partially coupled with mu receptor. Cytokine 12:1240-1242.
33. Trapp S, Tucker SJ, and Ashcroft FM (1998) Mechanism of ATP-sensitive K channel inhibition by sulfhydryl modification. J Gen Physiol 112:325-332.
34. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A, Esposito A, Chiariello M, and Ambrosio G (1997) Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 80:743-748.
35. Tsuchida A, Miura T, Tanno M, Nozawa Y, Kita H, and Shimamoto K (1998) Time window for the contribution of the delta-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart. Cardiovasc Drugs Ther 12:365-373.
36. Uchiyama Y, Otani H, Wakeno M, Okada T, Uchiyama T, Sumida T, Kido M, Imamura H, Nakao S, and Shingu K (2003) Role of mitochondrial KATP channels and protein kinase C in ischaemic preconditioning. Clin Exp Pharmacol Physiol 30:426-436.
37. Wang GY, Wu S, Pei JM, Yu XC, and Wong TM (2001a) Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol 280:H384-H391.
38. Wang GY, Zhou JJ, Shan J, and Wong TM (2001b) Protein kinase C-ε is a trigger of delayed cardioprotection against myocardial ischemia of κ-opioid receptor stimulation in rat ventricular myocytes. J Pharmacol Exp Ther 299:603-610.
39. Wei EP, Kontos HA, and Beckman JS (1998) Antioxidants inhibit ATP-sensitive potassium channels in cerebral arterioles. Stroke 29:817-822.
40. Wong TM, Lee AY, and Tai KK (1990) Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart-an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 22:1167-1175.
41. Wu S, Li HY, and Wong TM (1999) Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 84:1388-1395.
42. Yao Z, Tong J, Tan X, Li C, Shao Z, Kim WC, vanden Hoek TL, Becker LB, Head CA, and Schumacker PT (1999) Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am J Physiol 277:H2504-H2509.
43. Yue Y, Krenz M, Cohen MV, Downey JM, and Critz SD (2001) Menadione mimics the infarct-limiting effect of preconditioning in isolated rat hearts. Am J Physiol 281:H590-H595.
44. Yue Y, Qin Q, Cohen MV, Downey JM, and Critz SD (2002) The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res 55:681-689.